Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    24504442 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy
Condition: Sarcoma, Soft Tissue
Interventions: Drug: PAZOPANIB;   Drug: Placebo
2 Completed
Has Results
Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma
Condition: Sarcoma, Soft Tissue
Intervention: Drug: pazopanib

Indicates status has not been verified in more than two years